News > Teva Pharmaceuticals engages Honeywell to help reduce building energy use and carbon impact

Teva Pharmaceuticals engages Honeywell to help reduce building energy use and carbon impact

Teva Pharmaceutical Industries Ltd., a leading generic pharmaceutical company, (NYSE and TASE: TEVA) announced today that it is working with Honeywell (NASDAQ: HON) to help reduce energy consumption and carbon emissions at its Debrecen, Hungary, manufacturing facility.